FISKER INC (FSR)       7.63  +0.31 (+4.23%)

7.63  +0.31 (+4.23%)

US33813J1060 - Common Stock - After market: 7.54 -0.09 (-1.18%)


Fundamental Rating

2

Taking everything into account, FSR scores 2 out of 10 in our fundamental rating. FSR was compared to 33 industry peers in the Automobiles industry. The financial health of FSR is medium. Also its profitability is quite bad. While showing a medium growth rate, FSR is valued expensive at the moment.




Profitability

Profitability Rating

0

FSR has negative profitability rations, so we won't be analyzing them here.
FSR's Return On Assets of -36.53% is worse than the rest of the industry. The industry average Return On Assets is -15.46%.

FSR has a Profit Margin of -669901.30%. This is below the industry average of -2.81%. 100% of the industry peers outperform FSR.
FSR has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for FSR.
VS Industry

ROA (-36.53%) VS Industry: 34% outperformed.

-205.01
16.16

Profit Margin (-669901.3%) VS Industry: 0% outperformed.

-669,901.30
55,411.67

Valuation

Valuation Rating

1

With a price book ratio of 4.03, FSR is valued correctly.
FSR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FSR. No positive earnings are expected for the next year.
Compared to an average industry price book ratio of 1.76, FSR is valued more expensive than its industry peers.
VS Industry

Price/Book (4.03) VS Industry: 21% outperformed.

113.82
0.18

Growth

Growth Rating

5

The Revenue has grown by 24.19% in the past year. This is a very strong growth!
Based on estimates for the next 5 years, FSR will show a very strong growth in Revenue. The Revenue will grow by 4693.01% on average per year.

The Earnings Per Share is expected to grow by 9.03% on average over the next 5 years.
FSR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.98%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -42.98% -0.46% 13.6% 21.51% 9.03%
RevenueN/A N/A 24.19% 35415% 23931.9% 4972.4% 4693.01%

Health

Health Rating

4

FSR has a Current Ratio of 6.99. This indicates that FSR is financially healthy and has no problem in meeting its short term obligations.
FSR is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.74. FSR has a better rating than 84% of its industry peers.
FSR has a Quick Ratio of 6.99. This indicates that FSR is financially healthy and has no problem in meeting its short term obligations.
FSR is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.29. FSR has a better rating than 84% of its industry peers.

Compared to an average industry Debt to Equity Ratio of 0.19, FSR is requires more financing than its industry peers. 85% of its industry peers have a better Debt to Equity Ratio.
Based on the Altman-Z score of 0.24, we must say that FSR is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of FSR to the average industry Altman-Z score of 1.44, FSR is less financially healthy than its industry peers.
The Piotroski-F score of FSR is 2.00. This is a very weak score and indicates problems in health and profitability for FSR.
VS Industry

Debt/Equity (1.12) VS Industry: 15% outperformed.

3.87
0.00

Quick Ratio (6.99) VS Industry: 84% outperformed.

0.21
25.25

Current Ratio (6.99) VS Industry: 84% outperformed.

0.22
26.56

Altman-Z (0.24) VS Industry: 25% outperformed.

-11.41
21.34

Dividend

Dividend Rating

0

No dividends for FSR!.

FSR Daily chart

FISKER INC7.63

NYSE:FSR (12/2/2022, 7:04:01 PM)+0.31 (+4.23%)

After market: 7.54 -0.09 (-1.18%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Automobiles & Components
GICS Industry Automobiles
Earnings (Last) 11-02 2022-11-02/amc Earnings (Next) N/A N/A
Ins Owners 0.82% Inst Owners 27.24%
Market Cap 2.38B Analysts 67.5
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 30907.46 P/B 4.03
EV/EBITDA -4.56
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -42.98% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -32.43%
EPS Next Y -0.46% EPS Next 2Y 13.6%
EPS Next 3Y 21.51% EPS Next 5Y 9.03%
Revenue growth 1Y 24.19% Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q -6.67%
Revenue Next Year 35415% Revenue Next 2Y 23931.9%
Revenue Next 3Y 4972.4% Revenue Next 5Y 4693.01%
Health
Current Ratio 6.99 Quick Ratio 6.99
Altman-Z 0.24 F-Score 2
Debt/Equity 1.12 WACC 10.98%
ROIC/WACC N/A
Profitability
ROA -36.53% ROE N/A
ROICexgc N/A ROIC N/A
PM -669901.3% OM -630596.1%
Asset Turnover 0

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA